Development and interobserver reliability of a rating scale for lung ultrasound pathology in lower respiratory tract infection

Objectives The purpose of this study was to develop a severity rating scale for lung ultrasound pathology in lower respiratory tract infection based on multicenter expert consensus, and to test inter-rater reliability. Methods Ten point-of-care ultrasound experts from three academic institutions developed the scale iteratively through literature review, expert opinion, and pilot testing. Clips were prospectively collected from adults suspected of COVID-19 using a 14-zone scanning protocol. Blinded reviewers independently rated four data subsets. The rating scale was refined through eight consensus-building discussions reviewing challenging cases from the first three subsets. The final scale consisted of a set of ordinal scores from 0 to 4, for five sonographic findings: B-lines, pleural line abnormalities, consolidations, pleural effusions, and overall lung aeration. Ratings from the fourth subset were analyzed to determine reliability based on intraclass correlation coefficient (ICC). A total of 11,126 cine clips from 220 patients were acquired. Discussion After excluding uninterpretable clips, the test dataset contained 81 clips and yielded an average ICC of 0.70 across the five sonographic findings (0.76 for B-lines, 0.52 for pleural line abnormalities, 0.71 for consolidations, 0.80 for pleural effusions, and 0.70 for overall lung aeration). Improvements in agreement were observed with each successive review session and dataset rating. Conclusion The lung ultrasound severity scale established by multicenter expert consensus achieved moderate to good inter-rater reliability. The scale could be used clinically to standardize assessment of lower respiratory tract infection and in future studies to develop methods for automated interpretation of lung ultrasound pathology.

Emergency Department Point-Of-Care Echocardiography and Lung Ultrasound in Predicting COVID-19 Severity.

OBJECTIVES: We sought to determine if point-of-care ultrasound (POCUS) performed on patients with COVID-19 in the emergency department (ED) can help predict disease course, severity, or identify complications. METHODS: This was a retrospective cohort study of adult ED patients who tested positive for COVID-19 at hospital admission or within 2 weeks of presentation and received heart or lung POCUS. Clips were reviewed for presence of decreased left ventricular ejection fraction (LVEF), right ventricular dilation, presence of B-lines, and pleural line abnormalities. Patients with worsening hypoxemic respiratory failure or shock requiring higher level of care and patients who expired were considered to have developed severe COVID-19. Regression analysis was performed to determine if there was a correlation between ED POCUS findings and development of severe COVID-19. RESULTS: A total of 155 patients met study criteria; 148 patients had documented cardiac views and 116 patients had documented lung views (113 with both). Mean age was 66.5 years old (±18.6) and 53% of subjects were female. Subjects with decreased LVEF that was not previously documented had increased odds of having severe COVID during their hospitalization compared to those with old or no dysfunction (OR 5.66, 95% CI: 1.55-19.95, P = .08). The presence of pleural line abnormalities was also predictive for development of severe COVID (OR 2.68, 95% CI: 1.04-6.92, P = .04). CONCLUSION: POCUS findings of previously unidentified decreased LVEF and pleural line abnormalities in patients with COVID-19 evaluated in the ED were correlated to a more severe clinical course and worse prognosis.